Related references
Note: Only part of the references are listed.被撤回的出版物: Mfn2 Overexpression Attenuates Cardio-Cerebrovascular Ischemia-Reperfusion Injury Through Mitochondrial Fusion and Activation of the AMPK/Sirt3 Signaling (Retracted article. See vol. 10, 2022)
Min Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome
Lucia Ciranna et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Protective effects of PACAP in ischemia
Dora Reglodi et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Amyloid- Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease
Junxiang Yin et al.
MOLECULAR NEUROBIOLOGY (2018)
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease
N. Cabezas-Llobet et al.
MOLECULAR NEUROBIOLOGY (2018)
Sirtuin 3 attenuates amyloid-beta induced neuronal hypometabolism
Junxiang Yin et al.
AGING-US (2018)
Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors
Yuji Kaneko et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents
Dora Werling et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Dihydromyricetin Improves Hypobaric Hypoxia-Induced Memory Impairment via Modulation of SIRT3 Signaling
Peng Liu et al.
MOLECULAR NEUROBIOLOGY (2016)
Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid
David Calderon Guzman et al.
ACTA PHARMACEUTICA (2016)
THERAPEUTIC POTENTIAL OF PACAP FOR NEURODEGENERATIVE DISEASES
Rongqiang Yang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2015)
Models and mechanisms of vascular dementia
Poornima Venkat et al.
EXPERIMENTAL NEUROLOGY (2015)
PACAP as a neuroprotective factor in ischemic neuronal injuries
Seiji Shioda et al.
PEPTIDES (2015)
Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity
Pengcheng Han et al.
NEUROBIOLOGY OF AGING (2014)
Spatial memory tasks in rodents: what do they model?
Fabio Morellini
CELL AND TISSUE RESEARCH (2013)
PACAP Protects Against Salsolinol-Induced Toxicity in Dopaminergic SH-SY5Y Cells: Implication for Parkinson's Disease
Dwayne Brown et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
PACAP interactions in the mouse brain: Implications for behavioral and other disorders
George K. Acquaah-Mensah et al.
GENE (2012)
Intranasal administration of PACAP: Uptake by brain and regional brain targeting with cyclodextrins
Naoko Nonaka et al.
PEPTIDES (2012)
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP
Agnieszka Dejda et al.
BIOCHIMIE (2011)
PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity
Weifeng Xu
CURRENT OPINION IN NEUROBIOLOGY (2011)
Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice
Dorothea Rat et al.
FASEB JOURNAL (2011)
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
Albert Giralt et al.
MOLECULAR NEURODEGENERATION (2011)
BRAIN-DERIVED NEUROTROPHIC FACTOR MODULATES THE SEVERITY OF COGNITIVE ALTERATIONS INDUCED BY MUTANT huntingtin: INVOLVEMENT OF PHOSPHOLIPASECγ ACTIVITY AND GLUTAMATE RECEPTOR EXPRESSION
A. Giralt et al.
NEUROSCIENCE (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice
Danielle A. Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
Dipesh Chaudhury et al.
BMC NEUROSCIENCE (2008)
Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood
L. A. Glantz et al.
NEUROSCIENCE (2007)
Prevalence of dementia in the united states: The aging, demographics, and memory study
B. L. Plassman et al.
NEUROEPIDEMIOLOGY (2007)
Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6
Hirokazu Ohtaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Memory consolidation induces n-methyl-d-aspartic acid-receptor- and Ca2+/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties
LR Bevilaqua et al.
NEUROSCIENCE (2005)
Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals
D Reglödi et al.
REGULATORY PEPTIDES (2004)
Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay
LK Siew et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
D Vaudry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
